Related Experiment Video

Updated: Aug 8, 2026

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
14:59

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus

Published on: October 14, 2022

Hydrocephalus shunt infections

R Bayston1

  • 1Department of Microbial Diseases, City Hospital, Nottingham, UK.

The Journal of Antimicrobial Chemotherapy
|August 1, 1994
PubMed

Insights

Hydrocephalus shunt infections, common in infants, are difficult to diagnose. Treatment typically requires shunt removal, but new therapies show promise.

Area of Science:

  • Pediatric Neurology
  • Infectious Diseases
  • Neurosurgery

Background:

  • Hydrocephalus is commonly diagnosed in infancy, requiring cerebrospinal fluid shunts.
  • Shunts are susceptible to colonization by Staphylococcus epidermidis, particularly in infants.
  • Infant shunt infections are more frequent due to prolonged hospital stays and bacterial factors.

Purpose of the Study:

  • To review the diagnosis and treatment of cerebrospinal fluid shunt colonization and infections.
  • To highlight diagnostic challenges, especially in infants and the elderly.
  • To discuss current and emerging treatment strategies for shunt infections.

Main Methods:

  • Literature review of hydrocephalus shunt infections.
  • Analysis of diagnostic difficulties and serological test utility.
  • Evaluation of treatment outcomes for various therapeutic regimens.

Main Results:

  • Shunt colonization by Staphylococcus epidermidis is a significant complication.
  • Diagnosis of shunt colonization is challenging, with serological tests being crucial.
  • Effective treatment often involves shunt removal, though alternative strategies are under investigation.
  • Intraventricular vancomycin with intravenous rifampicin shows high success rates.

Conclusions:

  • Hydrocephalus shunt infections require prompt and effective management.
  • Accurate diagnosis, particularly in vulnerable populations, is critical.
  • Optimized treatment regimens, including novel intraventricular therapies, are essential for successful outcomes.

More Related Videos

Endoscopic Third Ventriculostomy and Pineal Biopsy from a Single Entry Point03:13

Endoscopic Third Ventriculostomy and Pineal Biopsy from a Single Entry Point

Published on: June 28, 2024

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats04:12

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats

Published on: March 28, 2025

Related Concept Videos

Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...